Objectives-Vein graft adaptation is characterized by loss of expression of the tyrosine kinase receptor Eph-B4, the embryonic determinant of venous identity, without increased expression of its ligand Ephrin-B2, the embryonic determinant of arterial identity. eNOS is an important mediator of vessel remodeling. We hypothesized that the mechanism of action of Eph-B4 during vein graft adaptation might be via regulation of downstream eNOS activity.
Methods-Mouse lung endothelial cells (MLEC)were stimulated with Ephrin-B2/Fc, without and with preclustering, without and with the eNOS inhibitor L-NAME or the Eph-B4 inhibitor NVP-BHG712, and assessed by Western blot and immunofluorescence for eNOS and Eph-B4 phosphorylation. Nitric oxide (NO) production was assessed using a NO-specific chemiluminescence analyzer. Cell migration was assessed using a transwell assay. Human and mouse vein graft specimens were examined for eNOS activity by Western blot, and vessel remodeling was assessed in vein grafts in wild-type (WT) or eNOS-knockout (KO) mice.Results-Ephrin-B2/Fc stimulated both Eph-B4 and eNOS phosphorylation in a bimodal temporal distribution (n=4; p<.05), with preclustered Ephrin-B2/Fc causing prolonged peak Eph-B4 and eNOS phosphorylation as well as altered subcellular localization (n=4; p<.05). Ephrin-B2/Fc increased NO release (n=3; p<.01) as well as increased endothelial cell migration (n=6; p<. 05) in an eNOS-dependent fashion. Both human and mouse vein grafts showed increased eNOS phosphorylation compared with normal veins (n=3; p<.05). Vein grafts from eNOS-KO mice showed less dilation and less wall thickening compared with WT vein grafts (n=7; p<.05).